Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at RecurrenceAndrea Marie Ibrahim, Michael Ong, Melanie Le May et al.|Annals of Surgical Oncology|2020Cited by 18
A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal CancerJean A. Maroun, G. Chiritescu, Horia Marginean et al.|Clinical Colorectal Cancer|2017Cited by 9
Impact of surveillance-detected metastatic recurrence on treatment outcomes of high-risk melanoma.Michael Ong, Andrea Marie Ibrahim, Carolyn Nessim et al.|Journal of Clinical Oncology|2018Cited by 1
Correction to: Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at RecurrenceAndrea Marie Ibrahim, Michael Ong, Melanie Le May et al.|Annals of Surgical Oncology|2020Cited by 1
Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early UseJoanna Gotfrit, Rachel Goodwin, Horia Marginean et al.|Current Oncology|2025Cited by 1